Golden
Recursion Pharmaceuticals

Recursion Pharmaceuticals

A biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated biological changes.

For diseases that can be modelled at the cellular level, Recursion uses automation in a massively parallel system to find potential treatments for disease. The initial focus was on repurposing existing drugs to treat rare diseases and has broadened to probe data for markers of inflammation, infectious disease and immunology. Recursion is using its technology to build a map of human cellular biology to increase the pace of discovering new treatments for patients. 



Neural networks and other computational techniques will be used to identify changes in thousands of cellular and subcellular features associated with various biological perturbations. This approach, termed phenomics, is the large scale study of phenotypes, the study of how variations in traits are related to genetic and environmental factors. Dr. Yoshua Bengio, a pioneer of deep learning is advising on their AI strategy. 

Products

REC-994

In 2018, an investigational new drug (IND) called REC-994 discovered by Recursion was FDA approved for clinical trials for treatment of cerebral cavernous malformation (CCM). CCM is a genetic disorder characterized by collections of enlarged and irregularly structured small blood vessels in the brain which alter blood flow and lead to symptoms like seizures, vision loss, hearing loss, paralysis, neurologic deficits and hemorrhagic stroke. 

Funding

Funding from the Bill and Melinda gates Foundation

Recursion received funding from the Bill and Melinda Gates Foundation in spring 2018 to use its technology to discover new drugs to treat malaria.

Timeline

People

Name
Role
Related Golden topics

Anne Carpenter

Advisor



Bart Robertson

Investor



Becca Parker

Employee



Ben Sukow

Employee



Blake Borgeson

Founder



brant corenson

Investor



Brian Bargh

Employee



Bril Flint

Investor



Britt McPartland

Employee



Brock Metcalf

Investor



Cedric St-Jean

Employee



Chadwick Davis

Employee



Chris Gibson

Founder



Christopher Johnson

Employee



Craig Dos Santos

Investor



CTAN - Central Texas Angel Network

Investor



Dan Graham

Investor



David Compton

Employee



Dean Li

Founder



Deena Kalai

Investor



Gary Rieschel

Investor



Gerald Lema

Investor



ian quigley

Employee



J.D. White

Employee



J.R. Kraft

Investor



SHOW ALL (43)

Further reading

Title
Author
Link
Type

Recursion Pharmaceuticals Raises $13M To Discover New Drugs Using Artificial Intelligence - Recursion Pharmaceuticals

Recursion Pharmaceuticals

Web

Recursion Pharmaceuticals Raises $60 Million to Industrialize Drug Discovery using Artificial Intelligence - Recursion Pharmaceuticals

Recursion Pharmaceuticals

Web

Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References